Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Advanced Medical Solutions ( (GB:AMS) ) just unveiled an update.
Advanced Medical Solutions reported record 2025 results, with group revenue rising 29% to £228.9m and adjusted EBITDA up 24% to £49.9m, driven by strong organic growth and the first full-year contribution from the Peters Surgical acquisition. Surgical division sales surged 36% at constant currency to £183.5m, buoyed by double-digit growth in LiquiBand adhesives, biosurgical devices and suture-related products, while the Advanced Woundcare unit grew 9% as restructuring took hold.
The company highlighted successful integration of Peters Surgical and Syntacoll, with commercial synergies already boosting sales and operational synergies targeted from 2027, alongside a robust innovation pipeline spanning adhesives, sutures, collagen technologies and bone substitutes. Net debt fell to £50.5m despite heavy investment in manufacturing transformation, and the board proposed a 10% dividend increase while signalling confidence that 2026 revenue and EBITDA will meet market expectations, underpinned by continued strength in Surgical and modest growth in Woundcare.
The most recent analyst rating on (GB:AMS) stock is a Hold with a £247.00 price target. To see the full list of analyst forecasts on Advanced Medical Solutions stock, see the GB:AMS Stock Forecast page.
Spark’s Take on AMS Stock
According to Spark, TipRanks’ AI Analyst, AMS is a Neutral.
Advanced Medical Solutions shows strong revenue growth and a solid capital structure, but faces challenges with declining profitability margins. Technical indicators suggest a positive trend, though valuation metrics indicate potential overvaluation. Recent corporate events highlight growth potential through strategic acquisitions and investor engagement.
To see Spark’s full report on AMS stock, click here.
More about Advanced Medical Solutions
Advanced Medical Solutions Group is a UK-based medical device company specialising in tissue-healing technologies for surgical and advanced wound care markets. Its portfolio spans skin adhesives and sealants, biosurgical devices, sutures, clips and collagen-based products, with a growing global presence supported by both direct sales channels and partnerships in key healthcare markets.
Average Trading Volume: 662,781
Technical Sentiment Signal: Sell
Current Market Cap: £425.9M
See more data about AMS stock on TipRanks’ Stock Analysis page.